Thanks Team and High_Hopes...This is the paragraph I was interested in:
The team plans to prospectively validate and market the predictive genetic test, called OVANOME, for a personalization of chemotherapy and an improvement in the overall first-line response rate for Ovarian Cancer chemotherapy.